{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T19:25:17Z","timestamp":1774380317015,"version":"3.50.1"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To compare the incidence of endophthalmitis after intravitreal injection with versus without topical antibiotic prophylaxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We systematically searched PubMed, Embase, and the Cochrane Library from each database's inception through August 2024. The primary outcome measure was the endophthalmitis rates after intravitreal injection, whereas the secondary outcomes included the distribution and quantity of microorganisms and best-corrected visual acuity changes. Study quality was assessed using the Newcastle\u2013Ottawa Scale. For the meta-analysis, pooled summary estimates were calculated using a random-effects model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Eighteen studies (3,138,778 intravitreal injections; 1,426 endophthalmitis cases) showed no significant difference in endophthalmitis incidence between prophylaxis and no-prophylaxis groups (odds ratio 1.85, 95% confidence interval [CI] 0.72\u20124.76;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.2). For microbial analysis, we selected 11 studies that demonstrated no significant difference in culture-positive rates between prophylaxis and nonprophylaxis groups (OR, 1.23; 95% CI, [0.53\u20122.84];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.63). Four studies provided best-corrected visual acuity changes from baseline to final follow-up, antibiotic prophylaxis group showed a decrease by 4.5 ETDRS letters compared with the no-prophylaxis group, although this difference was not statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.65).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Topical antibiotics did not reduce endophthalmitis risk or improve visual outcomes postintravitreal injection. Given potential risks, routine prophylaxis is not recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004687","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T19:01:40Z","timestamp":1758567700000},"page":"566-574","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["ASSOCIATION BETWEEN ANTIBIOTIC PROPHYLAXIS AND ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION"],"prefix":"10.1097","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0219-0448","authenticated-orcid":false,"given":"Xiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihui","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260324","first-page":"181","article-title":"2018 update on intravitreal injections: Euretina expert Consensus Recommendations","volume":"239","author":"Grzybowski","year":"2018"},{"key":"R2-20260324","first-page":"1449","article-title":"A systematic review of the adverse events of intravitreal anti-vascular endothelial growth factor injections","volume":"31","author":"Reis","year":"2011"},{"key":"R3-20260324","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ajo.2011.01.053","article-title":"Ocular complications after anti-vascular endothelial growth factor therapy in medicare patients with age-related macular degeneration","volume":"152","author":"Day","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"R4-20260324","doi-asserted-by":"crossref","first-page":"46","DOI":"10.37845\/ret.vit.2023.32.8","article-title":"The effect of topical antibiotic use on the incidence of endophthalmitis after intravitreal injection","volume":"32","author":"Kasal","year":"2023","journal-title":"J Retina-Vitreous"},{"key":"R5-20260324","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.3390\/pharmaceutics14102133","article-title":"Topical antibiotic prophylaxis and intravitreal injections: impact on the incidence of acute endophthalmitis-A nationwide study in France from 2009 to 2018","volume":"14","author":"Baudin","year":"2022","journal-title":"Pharmaceutics"},{"key":"R6-20260324","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/1120672120902028","article-title":"Incidence of endophthalmitis after intravitreal injection with and without topical antibiotic prophylaxis","volume":"31","author":"Torres-Costa","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"R7-20260324","doi-asserted-by":"crossref","first-page":"22122","DOI":"10.1038\/s41598-020-79377-w","article-title":"Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics","volume":"10","author":"Morioka","year":"2020","journal-title":"Scientific Rep"},{"key":"R8-20260324","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s10384-019-00684-5","article-title":"No increase in incidence of post-intravitreal injection endophthalmitis without topical antibiotics: a prospective study","volume":"63","author":"Tanaka","year":"2019","journal-title":"Jpn J Ophthalmol"},{"key":"R9-20260324","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41433-018-0187-z","article-title":"Post-injection endophthalmitis in eyes receiving vs. not receiving topical antibiotic prophylaxis in Northern Thailand","volume":"32","author":"Chaikitmongkol","year":"2018","journal-title":"Eye (London, England)"},{"key":"R10-20260324","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.12669\/pjms.345.14817","article-title":"Role of topical antibiotics in prophylaxis against endophthalmitis following intravitreal antibiotics","volume":"34","author":"Asghar","year":"2018","journal-title":"Pak J Med Sci"},{"key":"R11-20260324","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00417-015-3035-x","article-title":"The effect of prophylactic topical antibiotics on bacterial resistance patterns in endophthalmitis following intravitreal injection","volume":"254","author":"Storey","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R12-20260324","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1097\/IAE.0000000000000901","article-title":"Endophthalmitis after intravitreal injection: role of prophylactic topical ophthalmic antibiotics","volume":"36","author":"Li","year":"2016","journal-title":"Retina (Philadelphia, Pa)"},{"key":"R13-20260324","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/jamaophthalmol.2016.2741","article-title":"Elimination of topical antibiotics for intravitreous injections and the importance of using povidone-iodine: update from the diabetic retinopathy clinical research network","volume":"134","author":"Bhavsar","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"R14-20260324","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ophtha.2014.10.027","article-title":"Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT)","volume":"122","author":"Meredith","year":"2015","journal-title":"Ophthalmology"},{"key":"R15-20260324","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcjo.2014.09.005","article-title":"Endophthalmitis after resident-performed intravitreal bevacizumab injection","volume":"50","author":"Falavarjani","year":"2015","journal-title":"Can J Ophthalmol"},{"key":"R16-20260324","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jfo.2014.01.003","article-title":"Incidence of endophthalmitis after intravitreal injection: is antibioprophylaxis mandatory?","volume":"37","author":"Ramel","year":"2014","journal-title":"J Fr Ophtalmol"},{"key":"R17-20260324","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/IAE.0b013e31829f74b0","article-title":"Incidence of presumed endophthalmitis after intravitreal injection performed in the operating room: a retrospective multicenter study","volume":"34","author":"Casparis","year":"2014","journal-title":"Retina"},{"key":"R18-20260324","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.ophtha.2012.02.014","article-title":"Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections","volume":"119","author":"Cheung","year":"2012","journal-title":"Ophthalmology"},{"key":"R19-20260324","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1097\/IAE.0b013e31820f4b4f","article-title":"Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate","volume":"31","author":"Bhatt","year":"2011","journal-title":"Retina"},{"key":"R20-20260324","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/archophthalmol.2009.304","article-title":"Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials","volume":"127","author":"Bhavsar","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"R21-20260324","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s00347-007-1634-6","article-title":"Incidence of endophthalmitis after intravitreal Avastin injection with and without postoperative topical antibiotic application","volume":"104","author":"Meyer","year":"2007","journal-title":"Ophthalmologe"},{"key":"R22-20260324","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/IAE.0000000000000399","article-title":"Intravitreal injection technique and monitoring: updated guidelines of an expert panel","volume":"34","author":"Avery","year":"2014","journal-title":"Retina"},{"key":"R23-20260324","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1007\/s00417-023-06113-1","article-title":"Topical antibiotic prophylaxis before intravitreal injections: a pilot study","volume":"261","author":"Trovato Battagliola","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R24-20260324","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ophtha.2012.01.016","article-title":"Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection","volume":"119","author":"Milder","year":"2012","journal-title":"Ophthalmology"},{"key":"R25-20260324","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/jamaophthalmol.2013.2379","article-title":"Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection","volume":"131","author":"Yin","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"R26-20260324","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcjo.2013.09.008","article-title":"Resistance of ocular flora to gatifloxacin in patients undergoing intravitreal injections","volume":"49","author":"Dorrepaal","year":"2014","journal-title":"Can J Ophthalmol"},{"key":"R27-20260324","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R28-20260324","article-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses","author":"GA Wells"},{"key":"R29-20260324","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1111\/aos.14511","article-title":"Twenty years of endophthalmitis: incidence, aetiology and clinical outcome","volume":"99","author":"Malmin","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"R30-20260324","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0197-2456(98)00003-8","article-title":"The ischemic optic neuropathy decompression trial (IONDT): design and methods","volume":"19","author":"The IONDT Research Group","year":"1998","journal-title":"Controlled clinical trials"},{"key":"R31-20260324","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R32-20260324","doi-asserted-by":"crossref","first-page":"18088","DOI":"10.1038\/s41598-017-18412-9","article-title":"Intravitreal injections of anti-VEGF agents and antibiotic prophylaxis for endophthalmitis: a systematic review and meta-analysis","volume":"7","author":"Bande","year":"2017","journal-title":"Scientific Rep"},{"key":"R33-20260324","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/s41433-018-0138-8","article-title":"Antibiotic prophylaxis for preventing endophthalmitis after intravitreal injection: a systematic review","volume":"32","author":"Menchini","year":"2018","journal-title":"Eye (Lond)"},{"key":"R34-20260324","doi-asserted-by":"crossref","first-page":"e0156431","DOI":"10.1371\/journal.pone.0156431","article-title":"Antibioprophylaxis in prevention of endophthalmitis in intravitreal injection: a systematic review and meta-analysis","volume":"11","author":"Benoist d'Azy","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"R35-20260324","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3928\/23258160-20140306-08","article-title":"Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents","volume":"45","author":"Fileta","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R36-20260324","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1097\/IAE.0000000000001028","article-title":"Experimental visualization and quantification of vitreous contamination following intravitreal injections","volume":"36","author":"Nakashizuka","year":"2016","journal-title":"Retina"},{"key":"R37-20260324","first-page":"473","article-title":"Reducing oral flora contamination of intravitreal injections with face mask or silence","volume":"32","author":"Doshi","year":"2012","journal-title":"Retina"},{"key":"R38-20260324","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.ophtha.2010.12.014","article-title":"Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections","volume":"118","author":"Kim","year":"2011","journal-title":"Ophthalmology"},{"key":"R39-20260324","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/archophthalmol.2011.213","article-title":"Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a longitudinal controlled study of patients undergoing intravitreal injections","volume":"129","author":"Kim","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"R40-20260324","doi-asserted-by":"crossref","first-page":"605639","DOI":"10.3389\/fmed.2021.605639","article-title":"Conjunctival microbiota in patients with type 2 diabetes mellitus and influences of perioperative use of topical levofloxacin in ocular surgery","volume":"8","author":"Zhu","year":"2021","journal-title":"Front Med"},{"key":"R41-20260324","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.ajo.2013.09.007","article-title":"Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases","volume":"156","author":"Carifi","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"R42-20260324","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archophthalmol.2012.2348","article-title":"Evolving fluoroquinolone resistance among coagulase-negative Staphylococcus isolates causing endophthalmitis","volume":"130","author":"Schimel","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"R43-20260324","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12879-017-2264-5","article-title":"Comparison of methods for identifying causative bacterial microorganisms in presumed acute endophthalmitis: conventional culture, blood culture, and PCR","volume":"17","author":"Pongsachareonnont","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R44-20260324","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0002-9394(14)70380-0","article-title":"Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study","volume":"122","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"R45-20260324","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/24741264211028435","article-title":"Management patterns and outcomes for intravitreal injection-related endophthalmitis","volume":"6","author":"Soundararajan","year":"2022","journal-title":"J Vitreoretinal Dis"},{"key":"R46-20260324","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/aos.15719","article-title":"Pars plana vitrectomy versus intravitreal antibiotics for endophthalmitis management following intravitreal anti-VEGF agents: a meta-analysis","volume":"102","author":"Issa","year":"2024","journal-title":"Acta Ophthalmol"},{"key":"R47-20260324","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/ceo.14186","article-title":"Rapid treatment of endophthalmitis with intravitreal antibiotics is associated with better vision outcomes","volume":"51","author":"Michael","year":"2023","journal-title":"Clin Exp Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:07:30Z","timestamp":1774368450000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004687"}},"subtitle":["A Systematic Review and Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004687","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}